α-Glucosidase Inhibitors for Patients With Type 2 Diabetes-Reference-Cited by-同舟云学术

α-Glucosidase Inhibitors for Patients With Type 2 Diabetes

Published:2005-07-01 Issue:7 Volume:28 Page:1840-1840
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Hanefeld Markolf¹,Josse Robert G.²,Chiasson Jean-Louis³

Affiliation:

1. Centre for Clinical Studies, Science and Technology Transfer\NTechnical University Dresden, Dresden, Germany

2. 2Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Canada

3. 3Centre Hospitalier de l’Ùniversite de Montreal-Hotel-Dieu and Department of Medicine, Montreal University, Montreal, Canada

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/28/7/1840/568808/1840.pdf

Reference7 articles.

1. van de Laar FA, Lucassen PL, Akkermans RP, von de Lisdonk EH, Rutten GE, van Weel C: α-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care 28: 154–163, 2005

2. Holman RR, Cull CA, Turner RC: A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 22: 960–964, 1999 (erratum in Diabetes Care 22:1922, 1999)

3. Thompson SG: Biostatistics in Clinical Trials. Redmond CK, Colton T, Eds. Chichester, NY, Wiley, 2001

4. Committee for Propietary Medicinal Products: Points to Consider on Application With 1: Meta-analyses, 2: One Pivotal Study. London, European Agency for the Evaluation of Medicinal Products, 2001

5. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M: Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25: 10–16, 2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additional Benefit of Chinese Medicine Formulae Including Dioscoreae rhizome (Shanyao) for Diabetes Mellitus: Current State of Evidence;Frontiers in Endocrinology;2020-11-10

2. α-Glucosidase immobilization on functionalized Fe3O4 magnetic nanoparticles for screening of enzyme inhibitors;Chinese Chemical Letters;2019-03

3. Recommendations for management of diabetes and its complications during Hajj (Muslim pilgrimage);BMJ Open Diabetes Research & Care;2018-08

4. Inhibitory Effects of Phenolics and Saponins From Commonly Consumed Food Legumes in China Against Digestive Enzymes Pancreatic Lipase andα-Glycosidase;International Journal of Food Properties;2015-01-28

5. Metabolic dysfunction in diabetic cardiomyopathy;Heart Failure Reviews;2013-02-27